Reactivity of potential anti-diabetic molybdenum(VI) complexes in biological media: A XANES spectroscopic study

作者: Aviva Levina , Andrew I. McLeod , Jan Seuring , Peter A. Lay

DOI: 10.1016/J.JINORGBIO.2007.07.016

关键词:

摘要: The application of Mo(VI) complexes as anti-diabetic agents is a subject considerable recent interest. stability and speciation [Mo(VI)O(4)](2-) three analogs known V(IV) ([Mo(VI)O(2)L(2)]; where LH=2,4-pentanedione, l-cysteine ethyl ester or N,N-diethyldithiocarbamic acid) in natural simulated biological fluids (including blood its components, cell culture media, artificial digestion systems) were studied using MoK-edge XANES (X-ray absorption near-edge structure) spectroscopy freeze-dried samples at 20K. All the [MoO(2)L(2)] decomposed extensively under gastric intestinal conditions (3 h 310 K), well plasma medium (24 K). reaction products [MoO(4)](2-) with could be satisfactorily modelled (using multiple linear regression analyses) mixtures tetrahedral octahedral species (with O-donor ligands) various ratios, which dependent on nature rather than that initial compounds. Red cells take up predominantly form [MoO(4)](2-). Implications these results to development Mo(VI)-based anti-diabetics mechanisms uptake metabolism are discussed.

参考文章(29)
Mukul C. Chakravorti, Debasis Bandyopadhyay, Malcolm H. Chisholm, Charles E. Hammond, Dioxobis(2,4‐Pentanedionato)Molybdenum(VI), MoO2(acac)2 and μ‐Oxodioxotetrakis(2,4‐Pentanedionato)Dimolybdenum)(V), Mo2O3 (acac)4 Inorganic Syntheses, Volume 29. pp. 129- 134 ,(2007) , 10.1002/9780470132609.CH31
Shumei Yun, Jean-Pierre Habicht, Dennis D. Miller, Raymond P. Glahn, An In Vitro Digestion/Caco-2 Cell Culture System Accurately Predicts the Effects of Ascorbic Acid and Polyphenolic Compounds on Iron Bioavailability in Humans Journal of Nutrition. ,vol. 134, pp. 2717- 2721 ,(2004) , 10.1093/JN/134.10.2717
Fred William Moore, Melvin L. Larson, Dialkyldithiocarbamate complexes of molybdenum(V) and molybdenum(VI) Inorganic Chemistry. ,vol. 6, pp. 998- 1003 ,(1967) , 10.1021/IC50051A031
Sarah J Lord, Noah A Epstein, Robert L Paddock, Christopher M Vogels, Tracy L Hennigar, Michael J Zaworotko, Nicholas J Taylor, William R Driedzic, Tom L Broderick, Stephen A Westcott, Synthesis, characterization, and biological relevance of hydroxypyrone and hydroxypyridinone complexes of molybdenum Canadian Journal of Chemistry. ,vol. 77, pp. 1249- 1261 ,(1999) , 10.1139/V99-111
Jinping Li, Gerard Elberg, Dov Gefel, Yoram Shechter, Permolybdate and pertungstate--potent stimulators of insulin effects in rat adipocytes: mechanism of action. Biochemistry. ,vol. 34, pp. 6218- 6225 ,(1995) , 10.1021/BI00018A026
Hiromu Sakurai, Hiromi Watanabe, Hideyuki Tamura, Hiroyuki Yasui, Rokuji Matsushita, Jitsuya Takada, Insulin-mimetic vanadyl—dithiocarbamate complexes Inorganica Chimica Acta. ,vol. 283, pp. 175- 183 ,(1998) , 10.1016/S0020-1693(98)00309-0
A. Kay, P. C. H. Mitchell, Complexes of molydenum-(V) and -(VI) with L-cysteine and related compounds and their reactions with hydrogen sulphide Journal of the Chemical Society A: Inorganic, Physical, Theoretical. pp. 2421- 2428 ,(1970) , 10.1039/J19700002421
Ignacio Gimenez, Ricardo Garay, Jos� Octavio Alda, Molybdenum uptake through the anion exchanger in human erythrocytes Pflügers Archiv: European Journal of Physiology. ,vol. 424, pp. 245- 249 ,(1993) , 10.1007/BF00384349
Gayatri Sathyan, Roger R Dmochowski, Rodney A Appell, Cindy Guo, Suneel K Gupta, Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin Clinical Pharmacokinectics. ,vol. 43, pp. 1059- 1068 ,(2004) , 10.2165/00003088-200443140-00008